Systematic Evaluation of CRISPRa and CRISPRi Modalities Enables Development of a Multiplexed, Orthogonal Gene Activation and Repression System
Authors:
- 9 August 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 8 (9) , 1998-2006
Abstract
The ability to manipulate the expression of mammalian genes using synthetic transcription factors is highly desirable in both fields of basic research and industry for diverse applications, including stem cell reprogramming and differentiation, tissue engineering, and drug discovery. Orthogonal CRISPR systems can be used for simultaneous transcriptional upregulation of a subset of target genes while downregulating another subset, thus gaining control of gene regulatory networks, signaling pathways, and cellular processes whose activity depends on the expression of multiple genes. We have used a rapid and efficient modular cloning system to build and test in parallel diverse CRISPRa and CRISPRi systems and develop an efficient orthogonal gene regulation system for multiplexed and simultaneous up- and downregulation of endogenous target genes.Keywords
This publication has 38 references indexed in Scilit:
- Genetic and epigenetic control of gene expression by CRISPR–Cas systemsF1000Research, 2017
- CRISPR-Based Technologies for the Manipulation of Eukaryotic GenomesCell, 2017
- CRISPR/Cas9 in Genome Editing and BeyondAnnual Review of Biochemistry, 2016
- Beyond editing: repurposing CRISPR–Cas9 for precision genome regulation and interrogationNature Reviews Molecular Cell Biology, 2015
- Highly efficient Cas9-mediated transcriptional programmingNature Methods, 2015
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complexNature, 2014
- Genome-Scale CRISPR-Mediated Control of Gene Repression and ActivationCell, 2014
- CRISPR RNA–guided activation of endogenous human genesNature Methods, 2013
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in EukaryotesCell, 2013
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013